Our findings in human pancreatic cancer cell lines and primary human xenografts further extend these observations and implicate Bmi1 in inducing EMT and drug resistance thereby regulating pancreatic cancer growth and aggressiveness. This evidence concerns the gene BMI1 and familial pancreatic carcinoma.